| scholarly article | Q13442814 |
| P50 | author | Ilse Rooman | Q83181310 |
| Christine Sempoux | Q37831494 | ||
| Marina Pajic | Q38802477 | ||
| Mark J. Cowley | Q38802512 | ||
| Sean Grimmond | Q38802553 | ||
| Andrew Biankin | Q38802580 | ||
| Andreia V Pinho | Q56482259 | ||
| Nicola J Waddell | Q60503046 | ||
| Jian-min Wu | Q82105421 | ||
| P2093 | author name string | Amanda Mawson | |
| Patrick Jacquemin | |||
| Frédéric P Lemaigre | |||
| Marc Giry-Laterrière | |||
| Cécile Augereau | |||
| Adrien Grimont | |||
| Géraldine Van den Steen | |||
| P2860 | cites work | ERBIN: a basolateral PDZ protein that interacts with the mammalian ERBB2/HER2 receptor | Q22254439 |
| Sex reversal by loss of the C-terminal transactivation domain of human SOX9 | Q24313415 | ||
| The dimerization domain of SOX9 is required for transcription activation of a chondrocyte-specific chromatin DNA template | Q24313870 | ||
| Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
| Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes | Q24595981 | ||
| Core signaling pathways in human pancreatic cancers revealed by global genomic analyses | Q24606006 | ||
| Copy-number mutations on chromosome 17q24.2-q24.3 in congenital generalized hypertrichosis terminalis with or without gingival hyperplasia | Q24647433 | ||
| Genetically engineered mouse models of pancreatic adenocarcinoma | Q27002973 | ||
| A method and server for predicting damaging missense mutations | Q27860835 | ||
| EGF receptor is required for KRAS-induced pancreatic tumorigenesis | Q28584901 | ||
| SIFT: Predicting amino acid changes that affect protein function | Q29547211 | ||
| Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice | Q29617045 | ||
| Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse | Q29620396 | ||
| Identification of SOX9 interaction sites in the genome of chondrocytes | Q33559758 | ||
| Cross-talk between HER2 and MED1 regulates tamoxifen resistance of human breast cancer cells | Q34077845 | ||
| KOBAS server: a web-based platform for automated annotation and pathway identification | Q34974449 | ||
| Molecular signatures database (MSigDB) 3.0. | Q35019708 | ||
| KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases | Q35075729 | ||
| Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer | Q35832274 | ||
| A Notch-dependent molecular circuitry initiates pancreatic endocrine and ductal cell differentiation | Q36058628 | ||
| Quantitation of the effect of ErbB2 on epidermal growth factor receptor binding and dimerization | Q36225710 | ||
| EGF receptor signaling is essential for k-ras oncogene-driven pancreatic ductal adenocarcinoma | Q36696146 | ||
| Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy | Q37127423 | ||
| Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2/ErbB-2 | Q37191934 | ||
| Erbin regulates NRG1 signaling and myelination | Q37224245 | ||
| Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia | Q37501557 | ||
| Clinical and molecular characterization of HER2 amplified-pancreatic cancer. | Q37690146 | ||
| Pancreatic ductal adenocarcinoma and acinar cells: a matter of differentiation and development? | Q37897800 | ||
| New biomarkers and targets in pancreatic cancer and their application to treatment | Q38021692 | ||
| Chronic pancreatitis: a path to pancreatic cancer | Q38131933 | ||
| Maintenance of acinar cell organization is critical to preventing Kras-induced acinar-ductal metaplasia. | Q39337159 | ||
| Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice | Q40679145 | ||
| Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma | Q41856856 | ||
| Preexisting pancreatic acinar cells contribute to acinar cell, but not islet beta cell, regeneration. | Q42876632 | ||
| Let-7b and miR-495 stimulate differentiation and prevent metaplasia of pancreatic acinar cells by repressing HNF6. | Q43829038 | ||
| Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2/neu | Q45174616 | ||
| The sex-determining factors SRY and SOX9 regulate similar target genes and promote testis cord formation during testicular differentiation. | Q46017564 | ||
| Conditional inactivation of Sox9: a mouse model for campomelic dysplasia. | Q52123522 | ||
| Adult pancreatic acinar cells dedifferentiate to an embryonic progenitor phenotype with concomitant activation of a senescence programme that is present in chronic pancreatitis. | Q54394742 | ||
| A direct approach to false discovery rates | Q56622258 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 1790-1799 | |
| P577 | publication date | 2014-10-21 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | SOX9 regulates ERBB signalling in pancreatic cancer development | |
| P478 | volume | 64 |
| Q38922230 | Acinar cell plasticity and development of pancreatic ductal adenocarcinoma |
| Q37430812 | Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic Cancer |
| Q89285906 | Are Gastric and Esophageal Metaplasia Relatives? The Case for Barrett's Stemming from SPEM |
| Q38979853 | Chronic pancreatitis and lipomatosis are associated with defective function of ciliary genes in pancreatic ductal cells |
| Q91595228 | Differential impact of the ERBB receptors EGFR and ERBB2 on the initiation of precursor lesions of pancreatic ductal adenocarcinoma |
| Q92632442 | Dissecting Mechanisms of Melanoma Resistance to BRAF and MEK Inhibitors Revealed Genetic and Non-Genetic Patient- and Drug-Specific Alterations and Remarkable Phenotypic Plasticity |
| Q58697838 | Fibroblast Growth Factor 10 in Pancreas Development and Pancreatic Cancer |
| Q58790645 | Genome-scale analysis to identify prognostic microRNA biomarkers in patients with early stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy |
| Q36294213 | Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network |
| Q55516479 | Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemcitabine treatment. |
| Q42344431 | Inhibition of SOX9 may be an effective target for increasing radiosensitivity in gastrointestinal cancer. |
| Q41592795 | Integrated expression profiles analysis reveals novel predictive biomarker in pancreatic ductal adenocarcinoma |
| Q41070965 | Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer |
| Q47246517 | Luteolin inhibits pancreatitis‑induced acinar‑ductal metaplasia, proliferation and epithelial‑mesenchymal transition of acinar cells. |
| Q98906859 | MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity |
| Q55455064 | MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer. |
| Q46861963 | MicroRNA-30c-5p ameliorates hypoxia-reoxygenation-induced tubular epithelial cell injury via HIF1α stabilization by targeting SOCS3. |
| Q36413411 | MicroRNA-494 inhibits cell proliferation and invasion of chondrosarcoma cells in vivo and in vitro by directly targeting SOX9. |
| Q38907393 | New insights in the development of pancreatic cancer |
| Q26765235 | Pancreatic Cancer Genetics |
| Q90425919 | Plasticity of differentiated cells in wound repair and tumorigenesis, part I: stomach and pancreas |
| Q89576002 | Review and Meta-Analyses of TAAR1 Expression in the Immune System and Cancers |
| Q47616426 | SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer |
| Q92668907 | SOX9 promotes tumor progression through the axis BMI1-p21CIP |
| Q38753641 | Sirtuin 1 stimulates the proliferation and the expression of glycolysis genes in pancreatic neoplastic lesions |
| Q37301823 | Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling |
| Q39007517 | Targeting reactive oxygen species in development and progression of pancreatic cancer |
| Q56967209 | The BRG1/SOX9 axis is critical for acinar cell-derived pancreatic tumorigenesis |
| Q93092086 | The Influence of TGF-β3, EGF, and BGN on SOX9 and RUNX2 Expression in Human Chondrogenic Progenitor Cells |
| Q92091586 | Up-regulation of IGF2BP2 by multiple mechanisms in pancreatic cancer promotes cancer proliferation by activating the PI3K/Akt signaling pathway |
| Q42052094 | miR-206 inhibits non small cell lung cancer cell proliferation and invasion by targeting SOX9. |
Search more.